Clinical Report: Inflammatory CADASIL and Its Link to Multiple Sclerosis

Background

Multiple sclerosis is a complex autoimmune disease with symptoms that can overlap with other conditions, including CADASIL, a genetic disorder affecting blood vessels in the brain. Misdiagnosis can lead to inappropriate treatment, making it crucial for clinicians to recognize the distinguishing features of these conditions. Understanding the relationship between CADASIL and MS is essential for accurate diagnosis and management.

Data Highlights

In a study of patients with CADASIL, it was found that:

• Approximately 60% of patients with CADASIL exhibited neurological symptoms resembling those of MS.

• Magnetic resonance imaging (MRI) showed white matter lesions in both CADASIL and MS patients, complicating differential diagnosis.

• CSF analysis revealed oligoclonal bands in 30% of CADASIL patients, similar to findings in MS.

• Genetic testing confirmed NOTCH3 mutations in all CADASIL cases, providing a definitive diagnosis.

Key Findings

• CADASIL is caused by mutations in the NOTCH3 gene, leading to vascular dysfunction.

• Patients with CADASIL can present with symptoms and MRI findings similar to those of MS.

• CSF biomarkers like oligoclonal bands can be present in both CADASIL and MS, complicating diagnosis.

• Two cases were reported where patients diagnosed with MS were later found to have CADASIL after genetic testing.

• Atypical clinical features may serve as red flags for considering genetic testing in suspected MS cases.

Clinical Implications

Clinicians should be aware of the potential for CADASIL to mimic MS, particularly in patients with atypical presentations. Genetic testing may be warranted in cases where MS diagnosis is uncertain, especially when patients exhibit features that do not fully align with typical MS pathology.

Conclusion

The overlap between CADASIL and MS necessitates a careful diagnostic approach to avoid misdiagnosis and ensure appropriate treatment. Further research is needed to clarify the relationship between these two conditions.

Related Resources & Content

1. Acta Neuropathologica, 2024 -- Investigating the Distribution and Frequency of Spinal Cord Demyelination in Multiple Sclerosis: A Retrospective Analysis

2. Brain, 2024 -- Cerebral Microbleeds Observed in Taiwanese Individuals Diagnosed with Neuronal Intranuclear Inclusion Disease

3. Clinical Rheumatology, 2022 -- Cardiac Manifestations in Dermatomyositis Associated with Anti-MDA5 Antibodies: A Review of Case Studies

4. Diagnosing MS Using the 2024 McDonald Criteria | Cleveland Clinic

5. Frontiers in Immunology — Case Report: MECP2 and SH3KBP1 variants associated with autism spectrum disorder and immune dysregulation

6. Diagnosing MS Using the 2024 McDonald Criteria | Cleveland Clinic

7. Prevalence and Incidence of Paramagnetic Rim Lesions in Multiple Sclerosis: A Systematic Review and Meta-Analysis | Radiology

8. AAN Summary of Practice Guideline for Clinicians